{"paper_id": "59ad1b5afc3e701adefda449d6add27ca2585074", "metadata": {"title": "Novel Coronavirus Polymerase and Nucleotidyl-Transferase Structures: Potential to Target New Outbreaks", "authors": [{"first": "Wen-Fa", "middle": [], "last": "Zhang", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Preyesh", "middle": [], "last": "Stephen", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Jean-Francois", "middle": [], "last": "The\u0155iault", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Ruixuan", "middle": [], "last": "Wang", "suffix": "", "affiliation": {}, "email": ""}, {"first": "Sheng-Xiang", "middle": [], "last": "Lin", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [{"text": "The pandemic outbreak of a new coronavirus (CoV), SARS-CoV-2, has captured the world's attention, demonstrating that CoVs represent a continuous global threat. As this is a highly contagious virus, it is imperative to understand RNA-dependent-RNApolymerase (RdRp), the key component in virus replication. Although the SARS-CoV-2 genome shares 80% sequence identity with severe acute respiratory syndrome SARS-CoV, their RdRps and nucleotidyl-transferases (NiRAN) share 98.1% and 93.2% identity, respectively. Sequence alignment of six coronaviruses demonstrated higher identity among their RdRps (60.9%\u221298.1%) and lower identity among their Spike proteins (27%\u221277%). Thus, a 3D structural model of RdRp, NiRAN, non-structural protein 7 (nsp7), and nsp8 of SARS-CoV-2 was generated by modeling starting from the SARS counterpart structures. Furthermore, we demonstrate the binding poses of three viral RdRp inhibitors (Galidesivir, Favipiravir, and Penciclovir), which were recently reported to have clinical significance for SARS-CoV-2. The network of interactions established by these drug molecules affirms their efficacy to inhibit viral RNA replication and provides an insight into their structure-based rational optimization for SARS-CoV-2 inhibition.", "cite_spans": [], "ref_spans": [], "section": "Abstract"}], "body_text": [{"text": "T o date (May 11, 2020), more than 3.9 million worldwide cases of infection and 274 000 deaths have been attributed to the novel coronavirus, SARS-CoV-2, since its emergence in December 2019. This new viral disease has spread to more than 210 countries with an increasing number of people still being infected. Furthermore, human-to-human transmission 1,2 of SARS-CoV-2 has been confirmed and virus survival on hard surfaces for longer time periods has been reported. 3 Coronaviruses (CoVs), a type of RNA virus, are enveloped viruses with a single-strand, positive-sense RNA genome of approximately 26\u221232 kilobases in size. Known examples include severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). 4 The latest reports show that the closest relatives to SARS-CoV-2 are the bat SARS-related coronaviruses found in Chinese horseshoe bats as determined by phylogenetic analysis and next-generation sequencing. 2 The SARS-CoV-2 genome shares 88% sequence identity with two bat-derived SARS-like coronaviruses (bat-SL-CoVZC45 and bat-SL-CoVZXC21), approximately 79% with SARS-CoV, and 50% with MERS-CoV. 2 Homology modeling revealed that SARS-CoV-2 has a receptor-binding domain structure similar to that of SARS-CoV. 2 The RNA-dependent RNA polymerase (RdRp) of SARS-CoV is essential for viral replication and is a potential target for anti-SARS drugs. 5 Crystal structures of RdRps from different RNA viruses have revealed key aspects in the structural biology of RdRps and confirmed the hypothesis that RdRps share a common architecture and mechanism of polymerase catalysis. 6, 7 No mammalian cells have been shown to encode any RdRp or its equivalent; therefore, inhibition of RdRp is not anticipated to result in undesirable side effects during therapy. 8 Recently reported attempts to treat SARS-CoV-2 infections by targeting RdRp using an antiviral drug currently under clinical assay, Remdesivir, support the necessity for our structural study on the virus RdRp. 9 The sequences of SARS-CoV-2 nonstructural protein12 (nsp12, 932 amino acids [a.a.s]), RdRp protein (part of nsp12, 535 a.a.s), and Spike protein (1273 a.a.s) were aligned with 5 other strains of human coronaviruses (Table 1 and  Supplementary Table 1 ). Sequence alignments and comparisons indicate that SARS-CoV-2 RdRp shares a high sequence identity with other coronavirus RdRps (60.9%\u221298.1%). However, SARS-CoV-2 Spike has a significantly lower sequence identity with other coronavirus Spikes (27.4%\u2212 77.4%). Moreover, both protein sequences of SARS-CoV-2 have a higher identity with SARS-CoV compared with other CoVs. This higher sequence conservation among RdRps in the coronavirus family compared with Spike protein supports the argument of finding an inhibitor of RdRp in combating the novel outbreaks. 10 In addition, a sequence comparison between SARS-CoV and SARS-CoV-2 has revealed 96.4% identity between nsp12s, with RdRps showing a slightly higher identity of 98.1%.", "cite_spans": [{"start": 468, "end": 469, "text": "3", "ref_id": "BIBREF2"}, {"start": 766, "end": 767, "text": "4", "ref_id": "BIBREF3"}, {"start": 975, "end": 976, "text": "2", "ref_id": "BIBREF1"}, {"start": 1167, "end": 1168, "text": "2", "ref_id": "BIBREF1"}, {"start": 1281, "end": 1282, "text": "2", "ref_id": "BIBREF1"}, {"start": 1417, "end": 1418, "text": "5", "ref_id": "BIBREF4"}, {"start": 1642, "end": 1644, "text": "6,", "ref_id": "BIBREF5"}, {"start": 1645, "end": 1646, "text": "7", "ref_id": "BIBREF6"}, {"start": 1823, "end": 1824, "text": "8", "ref_id": "BIBREF7"}, {"start": 2035, "end": 2036, "text": "9", "ref_id": "BIBREF8"}, {"start": 2847, "end": 2849, "text": "10", "ref_id": "BIBREF9"}], "ref_spans": [{"start": 2252, "end": 2287, "text": "(Table 1 and  Supplementary Table 1", "ref_id": "TABREF0"}], "section": ""}, {"text": "Structural studies of RdRp and NiRAN were performed using Modeler v9.23. Because of the lack of a suitable template, only a.a.s from 117\u2212895 of nsp12 were modeled. During revision of this Letter, the crystal structure of this RdRp in complex with cofactors was made available in the PDB (ID: 6M71). 11 An r.m.s.d. of 0.5 \u00c5 between the crystal structure and our model indicates the quality of the structure we modeled. The SARS-CoV-2 nsp12 ( Figure 1B ) and SARS-CoV nsp12 structures ( Figure 1C ) showed high similarity. The nsp12 protein has been reported to have an N-terminal nidovirus RdRp-associated nucleotidyl-transferase (NiRAN) (a.a.s 1\u2212 250), and a C-terminal RdRp (a.a.s 398\u2212932) connected by an interface domain ( Figure 1A) . 7, 12 NiRAN is essential for replication of SARS-CoV and other nidoviruses and can be involved in nucleic acid ligation, mRNA capping, and proteinprimed RNA synthesis. 13 However, the mechanism of its nucleotidyl-transferase activity is still not completely clear. We found that the NiRAN sequence of SARS-CoV-2 showed 93.2% identity with SARS-CoV. A total of 17 substituted a.a.s appeared in SARS-CoV-2. However, the well-conserved a.a.s, Lys 73 , Arg 116 , Thr 123 , Asp 126 , Asp 218 , and Phe 219 , were unchanged. 7 Meanwhile, RdRp showed a very high similarity of 98.1% with only 10 substitutions. RdRp comprises a finger domain, a palm domain, and a thumb domain. The finger domain revealed two important conserved motifs named motif G and motif F. The palm domain forms the catalytic core of the polymerase and has four conserved motifs, A to D, and part of motif E. Considering the structure of the modeled nsp12 protein, the NiRAN domain may engage in a functional interaction with the palm domain as these two domains are in close spatial proximity. In comparison with SARS-CoV, three substitutions were apparent in the polymerization zone: Figure 2C ). These changes are located at the start of the finger domain (a.a.s 405\u2212448, colored orange and cyan, respectively) and thumb domain (a.a.s 835\u2212895, colored pink and cyan, respectively). Because of the high a.a. sequence identity, the difference appears to be minimal. Two cofactors for RdRp nsp7 and nsp8 have also been modeled ( Figure 2D,E) . Both nsp7 and nsp8 play essential roles in the formation and activity of RNA synthesis machinery. 14 Although the function of nsp7 and nsp8 in RNA synthesis is not completely elucidated, they may act as processivity factors on RdRp by extending primed RNA templates and boosting the activity of RdRp. 15, 16 In SARS-CoV, nsp7 and nsp8 may form a super complex assembled from eight copies of nsp8 that are held tightly together by eight copies of nsp7. 12, 15 Nsp7 in SARS-CoV-2 and SARS-CoV have 83 a.a.s with only one substitution Arg 70 Lys. Superimposition analysis showed structural changes at the terminal region, possibly imposed by Arg 70 Lys substitution ( Figure 2D ). The nsp8 sequences showed 97.5% similarity with only 5 substitutions and formation of the well-known \"golf-club\" structure ( Figure 2E ). 15 Superimposition analysis found no significant change to their structure.", "cite_spans": [{"start": 299, "end": 301, "text": "11", "ref_id": "BIBREF10"}, {"start": 739, "end": 741, "text": "7,", "ref_id": "BIBREF6"}, {"start": 742, "end": 744, "text": "12", "ref_id": "BIBREF11"}, {"start": 907, "end": 909, "text": "13", "ref_id": "BIBREF12"}, {"start": 1258, "end": 1259, "text": "7", "ref_id": "BIBREF6"}, {"start": 2550, "end": 2553, "text": "15,", "ref_id": "BIBREF14"}, {"start": 2554, "end": 2556, "text": "16", "ref_id": "BIBREF15"}, {"start": 2701, "end": 2704, "text": "12,", "ref_id": "BIBREF11"}, {"start": 2705, "end": 2707, "text": "15", "ref_id": "BIBREF14"}, {"start": 3065, "end": 3067, "text": "15", "ref_id": "BIBREF14"}], "ref_spans": [{"start": 441, "end": 450, "text": "Figure 1B", "ref_id": "FIGREF0"}, {"start": 485, "end": 494, "text": "Figure 1C", "ref_id": "FIGREF0"}, {"start": 726, "end": 736, "text": "Figure 1A)", "ref_id": "FIGREF0"}, {"start": 1891, "end": 1900, "text": "Figure 2C", "ref_id": "FIGREF1"}, {"start": 2234, "end": 2246, "text": "Figure 2D,E)", "ref_id": "FIGREF1"}, {"start": 2914, "end": 2923, "text": "Figure 2D", "ref_id": "FIGREF1"}, {"start": 3052, "end": 3061, "text": "Figure 2E", "ref_id": "FIGREF1"}], "section": ""}, {"text": "Knowledge of the nsp12 structure permitted us to test drug\u2212RdRp interactions. Docking analyses of three drugs that target RdRps including Galidesivir, 17 Favipiravir, 18, 19 and Penciclovir 19 were performed using the program CCDC GOLD. Galidesivir (originally developed for hepatitis C), Penciclovir (used for the treatment of various herpesvirus infections), and Favipiravir (used to treat influenza in Japan) are reported to have clinical significance in treating COVID patients. ATP was included as a positive control. The triphosphate of all the molecules docked near the conserved catalytic center Asp 760 and Asp 761 in motif C 7,12 (Figure 3 and Supporting Information). Analysis of docking poses revealed a significant number of protein\u2212ligand interactions including hydrogen bond and hydrophobic interactions (Table 2 and Supporting Information). Many of the amino acids interacting with ATP were observed to establish contacts with the drug molecules. Galidesivir established four hydrophobic and six hydrogen bond interactions with nsp12. Favipiravir established 20\u221222 was also shown to make contacts with all three drug molecules. Galidesivir and Penciclovir made contacts with Asn 691 , which help in sugar selection. 20, 21 The drug molecules may all interfere with metal ion chelation as they have been shown to interact with Asp 618 , Asp 760 , and Asp 761 , which are important in metal ion chelation. 20\u221224 In conclusion, docking analysis demonstrated that the clinically used antiviral drugs Galidesivir, Favipiravir, and Penciclovir can bind to the catalytic center of SARS CoV-2 RdRp, establishing various hydrogen bond and hydrophobic interactions. Understanding the binding mechanism of the drug molecules may assist in optimizing these drug molecules to efficiently target the RdRp of SARS-CoV-2. Moreover, the remarkably high structural conservation among RdRps of coronaviruses strongly suggests their potential as therapeutic targets by implementing improvements to available inhibitors of key viral enzymes when an unprecedented rapid response is required.", "cite_spans": [{"start": 151, "end": 153, "text": "17", "ref_id": "BIBREF16"}, {"start": 167, "end": 170, "text": "18,", "ref_id": "BIBREF17"}, {"start": 171, "end": 173, "text": "19", "ref_id": "BIBREF18"}, {"start": 190, "end": 192, "text": "19", "ref_id": "BIBREF18"}, {"start": 1075, "end": 1080, "text": "20\u221222", "ref_id": null}, {"start": 1232, "end": 1235, "text": "20,", "ref_id": "BIBREF20"}, {"start": 1236, "end": 1238, "text": "21", "ref_id": "BIBREF21"}, {"start": 1420, "end": 1425, "text": "20\u221224", "ref_id": null}], "ref_spans": [{"start": 640, "end": 649, "text": "(Figure 3", "ref_id": "FIGREF2"}, {"start": 819, "end": 827, "text": "(Table 2", "ref_id": "TABREF2"}], "section": ""}, {"text": "\u25a0 ASSOCIATED CONTENT", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jpclett.0c00571.", "cite_spans": [], "ref_spans": [], "section": "* s\u0131 Supporting Information"}, {"text": "Materials and Methods; nsp12, nsp7, and nsp8 sequence used for modeling; RMSD value of nsp12, nsp7, and nsp8 model (Supplementary Table 1 ); Ramachandran plot for nsp12, nsp7, and nsp8 model (Supplementary Figure 1) ; interactions of docked complexes of ATP, Galidesivir, Favipiravir, and Penciclovir with RdRp (Supplementary Figure 2 ) (PDF)", "cite_spans": [], "ref_spans": [{"start": 130, "end": 137, "text": "Table 1", "ref_id": "TABREF0"}, {"start": 206, "end": 215, "text": "Figure 1)", "ref_id": "FIGREF0"}, {"start": 326, "end": 334, "text": "Figure 2", "ref_id": "FIGREF1"}], "section": "* s\u0131 Supporting Information"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster", "authors": [{"first": "J", "middle": ["F"], "last": "Chan", "suffix": ""}, {"first": ".-W", "middle": [], "last": "Yuan", "suffix": ""}, {"first": "S", "middle": [], "last": "Kok", "suffix": ""}, {"first": "K.-H", "middle": [], "last": "To", "suffix": ""}, {"first": "K", "middle": ["K"], "last": "", "suffix": ""}, {"first": ".-W", "middle": [], "last": "Chu", "suffix": ""}, {"first": "H", "middle": [], "last": "Yang", "suffix": ""}, {"first": "J", "middle": [], "last": "Xing", "suffix": ""}, {"first": "F", "middle": [], "last": "Liu", "suffix": ""}, {"first": "J", "middle": [], "last": "Yip", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "", "suffix": ""}, {"first": ".-Y", "middle": [], "last": "Poon", "suffix": ""}, {"first": "R", "middle": ["W"], "last": "", "suffix": ""}, {"first": ".-S", "middle": [], "last": "", "suffix": ""}], "year": 2020, "venue": "Lancet", "volume": "395", "issn": "", "pages": "514--523", "other_ids": {"DOI": ["10.1016/S0140-6736(20)30154-9"]}}, "BIBREF1": {"ref_id": "b1", "title": "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding", "authors": [{"first": "R", "middle": [], "last": "Lu", "suffix": ""}, {"first": "X", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "J", "middle": [], "last": "Li", "suffix": ""}, {"first": "P", "middle": [], "last": "Niu", "suffix": ""}, {"first": "B", "middle": [], "last": "Yang", "suffix": ""}, {"first": "H", "middle": [], "last": "Wu", "suffix": ""}, {"first": "W", "middle": [], "last": "Wang", "suffix": ""}, {"first": "H", "middle": [], "last": "Song", "suffix": ""}, {"first": "B", "middle": [], "last": "Huang", "suffix": ""}, {"first": "N", "middle": [], "last": "Zhu", "suffix": ""}], "year": null, "venue": "Lancet", "volume": "2020", "issn": "", "pages": "565--574", "other_ids": {"DOI": ["10.1016/S0140-6736(20)30251-8"]}}, "BIBREF2": {"ref_id": "b2", "title": "Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1", "authors": [{"first": "N", "middle": [], "last": "Van Doremalen", "suffix": ""}, {"first": "T", "middle": [], "last": "Bushmaker", "suffix": ""}, {"first": "D", "middle": ["H"], "last": "Morris", "suffix": ""}, {"first": "M", "middle": ["G"], "last": "Holbrook", "suffix": ""}, {"first": "A", "middle": [], "last": "Gamble", "suffix": ""}, {"first": "B", "middle": ["N"], "last": "Williamson", "suffix": ""}, {"first": "A", "middle": [], "last": "Tamin", "suffix": ""}, {"first": "J", "middle": ["L"], "last": "Harcourt", "suffix": ""}, {"first": "N", "middle": ["J"], "last": "Thornburg", "suffix": ""}, {"first": "S", "middle": ["I"], "last": "Gerber", "suffix": ""}], "year": null, "venue": "N. Engl. J. Med", "volume": "2020", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1056/NEJMc2004973"]}}, "BIBREF3": {"ref_id": "b3", "title": "Epidemiology, genetic recombination, and pathogenesis of coronaviruses", "authors": [{"first": "S", "middle": [], "last": "Su", "suffix": ""}, {"first": "G", "middle": [], "last": "Wong", "suffix": ""}, {"first": "W", "middle": [], "last": "Shi", "suffix": ""}, {"first": "J", "middle": [], "last": "Liu", "suffix": ""}, {"first": "A", "middle": ["C"], "last": "Lai", "suffix": ""}, {"first": "J", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "W", "middle": [], "last": "Liu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Bi", "suffix": ""}, {"first": "G", "middle": ["F"], "last": "Gao", "suffix": ""}], "year": 2016, "venue": "Trends Microbiol", "volume": "24", "issn": "6", "pages": "490--502", "other_ids": {"DOI": ["10.1016/j.tim.2016.03.003"]}}, "BIBREF4": {"ref_id": "b4", "title": "Expression, purification, and characterization of SARS coronavirus RNA polymerase", "authors": [{"first": "A", "middle": [], "last": "Cheng", "suffix": ""}, {"first": "W", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "Y", "middle": [], "last": "Xie", "suffix": ""}, {"first": "W", "middle": [], "last": "Jiang", "suffix": ""}, {"first": "E", "middle": [], "last": "Arnold", "suffix": ""}, {"first": "S", "middle": ["G"], "last": "Sarafianos", "suffix": ""}, {"first": "J", "middle": [], "last": "Ding", "suffix": ""}], "year": 2005, "venue": "Virology", "volume": "335", "issn": "2", "pages": "165--176", "other_ids": {"DOI": ["10.1016/j.virol.2005.02.017"]}}, "BIBREF5": {"ref_id": "b5", "title": "Primary structural comparison of RNAdependent polymerases from plant, animal and bacterial viruses", "authors": [{"first": "G", "middle": [], "last": "Kamer", "suffix": ""}, {"first": "P", "middle": [], "last": "Argos", "suffix": ""}], "year": 1984, "venue": "Nucleic Acids Res", "volume": "12", "issn": "18", "pages": "7269--7282", "other_ids": {"DOI": ["10.1093/nar/12.18.7269"]}}, "BIBREF6": {"ref_id": "b6", "title": "Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design", "authors": [{"first": "X", "middle": [], "last": "Xu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Liu", "suffix": ""}, {"first": "S", "middle": [], "last": "Weiss", "suffix": ""}, {"first": "E", "middle": [], "last": "Arnold", "suffix": ""}, {"first": "S", "middle": ["G"], "last": "Sarafianos", "suffix": ""}, {"first": "J", "middle": [], "last": "Ding", "suffix": ""}], "year": 2003, "venue": "Nucleic acids research", "volume": "31", "issn": "24", "pages": "", "other_ids": {"DOI": ["10.1093/nar/gkg916"]}}, "BIBREF7": {"ref_id": "b7", "title": "Human SARS-coronavirus RNA-dependent RNA polymerase: Activity determinants and nucleoside analogue inhibitors", "authors": [{"first": "A", "middle": [], "last": "Azzi", "suffix": ""}, {"first": "S", "middle": ["X"], "last": "Lin", "suffix": ""}], "year": 2004, "venue": "Proteins: Struct., Funct., Genet", "volume": "57", "issn": "1", "pages": "12--14", "other_ids": {"DOI": ["10.1002/prot.20194"]}}, "BIBREF8": {"ref_id": "b8", "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "authors": [{"first": "M", "middle": [], "last": "Wang", "suffix": ""}, {"first": "R", "middle": [], "last": "Cao", "suffix": ""}, {"first": "L", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "X", "middle": [], "last": "Yang", "suffix": ""}, {"first": "J", "middle": [], "last": "Liu", "suffix": ""}, {"first": "M", "middle": [], "last": "Xu", "suffix": ""}, {"first": "Z", "middle": [], "last": "Shi", "suffix": ""}, {"first": "Z", "middle": [], "last": "Hu", "suffix": ""}, {"first": "W", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "G", "middle": [], "last": "Xiao", "suffix": ""}], "year": 2020, "venue": "Cell Res", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1038/s41422-020-0282-0"]}}, "BIBREF9": {"ref_id": "b9", "title": "The spike protein of SARS-CoV\ue0d5a target for vaccine and therapeutic development", "authors": [{"first": "L", "middle": [], "last": "Du", "suffix": ""}, {"first": "Y", "middle": [], "last": "He", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "S", "middle": [], "last": "Liu", "suffix": ""}, {"first": "B.-J", "middle": [], "last": "Zheng", "suffix": ""}, {"first": "S", "middle": [], "last": "Jiang", "suffix": ""}], "year": 2009, "venue": "Nat. Rev. Microbiol", "volume": "7", "issn": "3", "pages": "226--236", "other_ids": {"DOI": ["10.1038/nrmicro2090"]}}, "BIBREF10": {"ref_id": "b10", "title": "Structure of the RNA-dependent RNA polymerase from COVID-19 virus", "authors": [{"first": "Y", "middle": [], "last": "Gao", "suffix": ""}, {"first": "L", "middle": [], "last": "Yan", "suffix": ""}, {"first": "Y", "middle": [], "last": "Huang", "suffix": ""}, {"first": "F", "middle": [], "last": "Liu", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhao", "suffix": ""}, {"first": "L", "middle": [], "last": "Cao", "suffix": ""}, {"first": "T", "middle": [], "last": "Wang", "suffix": ""}, {"first": "Q", "middle": [], "last": "Sun", "suffix": ""}, {"first": "Z", "middle": [], "last": "Ming", "suffix": ""}, {"first": "L", "middle": [], "last": "Zhang", "suffix": ""}], "year": 2020, "venue": "Science", "volume": "", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1126/science.abb7498"]}}, "BIBREF11": {"ref_id": "b11", "title": "Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors", "authors": [{"first": "R", "middle": ["N"], "last": "Kirchdoerfer", "suffix": ""}, {"first": "A", "middle": ["B"], "last": "Ward", "suffix": ""}], "year": 2019, "venue": "Nat. Commun", "volume": "10", "issn": "1", "pages": "1--9", "other_ids": {"DOI": ["10.1038/s41467-019-10280-3"]}}, "BIBREF12": {"ref_id": "b12", "title": "Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerasecontaining protein of all nidoviruses", "authors": [{"first": "K", "middle": ["C"], "last": "Lehmann", "suffix": ""}, {"first": "A", "middle": [], "last": "Gulyaeva", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Zevenhoven-Dobbe", "suffix": ""}, {"first": "G", "middle": ["M"], "last": "Janssen", "suffix": ""}, {"first": "M", "middle": [], "last": "Ruben", "suffix": ""}, {"first": "H", "middle": ["S"], "last": "Overkleeft", "suffix": ""}, {"first": "P", "middle": ["A"], "last": "Van Veelen", "suffix": ""}, {"first": "D", "middle": ["V"], "last": "Samborskiy", "suffix": ""}, {"first": "A", "middle": ["A"], "last": "Kravchenko", "suffix": ""}, {"first": "A", "middle": ["M"], "last": "Leontovich", "suffix": ""}], "year": 2015, "venue": "Nucleic Acids Res", "volume": "", "issn": "17", "pages": "8416--8434", "other_ids": {"DOI": ["10.1093/nar/gkv838"]}}, "BIBREF13": {"ref_id": "b13", "title": "Imbert, I. One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities", "authors": [{"first": "L", "middle": [], "last": "Subissi", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "Posthuma", "suffix": ""}, {"first": "A", "middle": [], "last": "Collet", "suffix": ""}, {"first": "J", "middle": ["C"], "last": "Zevenhoven-Dobbe", "suffix": ""}, {"first": "A", "middle": ["E"], "last": "Gorbalenya", "suffix": ""}, {"first": "E", "middle": [], "last": "Decroly", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Snijder", "suffix": ""}, {"first": "B", "middle": [], "last": "Canard", "suffix": ""}], "year": 2014, "venue": "Proc. Natl. Acad. Sci. U. S. A", "volume": "111", "issn": "37", "pages": "3900--3909", "other_ids": {"DOI": ["10.1073/pnas.1323705111"]}}, "BIBREF14": {"ref_id": "b14", "title": "Insights into SARS-CoV transcription and replication from the structure of the nsp7\u2212nsp8 hexadecamer", "authors": [{"first": "Y", "middle": [], "last": "Zhai", "suffix": ""}, {"first": "F", "middle": [], "last": "Sun", "suffix": ""}, {"first": "X", "middle": [], "last": "Li", "suffix": ""}, {"first": "H", "middle": [], "last": "Pang", "suffix": ""}, {"first": "X", "middle": [], "last": "Xu", "suffix": ""}, {"first": "M", "middle": [], "last": "Bartlam", "suffix": ""}, {"first": "Z", "middle": [], "last": "Rao", "suffix": ""}], "year": 2005, "venue": "Nat. Struct. Mol. Biol", "volume": "12", "issn": "11", "pages": "980--986", "other_ids": {"DOI": ["10.1038/nsmb999"]}}, "BIBREF15": {"ref_id": "b15", "title": "The SARS-coronavirus nsp7+ nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension", "authors": [{"first": "Te", "middle": [], "last": "Velthuis", "suffix": ""}, {"first": "A", "middle": ["J"], "last": "Van Den Worm", "suffix": ""}, {"first": "S", "middle": ["H"], "last": "Snijder", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "", "suffix": ""}], "year": 2012, "venue": "Nucleic Acids Res", "volume": "40", "issn": "4", "pages": "1737--1747", "other_ids": {"DOI": ["10.1093/nar/gkr893"]}}, "BIBREF16": {"ref_id": "b16", "title": "Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430", "authors": [{"first": "T", "middle": ["K"], "last": "Warren", "suffix": ""}, {"first": "J", "middle": [], "last": "Wells", "suffix": ""}, {"first": "R", "middle": ["G"], "last": "Panchal", "suffix": ""}, {"first": "K", "middle": ["S"], "last": "Stuthman", "suffix": ""}, {"first": "N", "middle": ["L"], "last": "Garza", "suffix": ""}, {"first": "S", "middle": ["A"], "last": "Van Tongeren", "suffix": ""}, {"first": "L", "middle": [], "last": "Dong", "suffix": ""}, {"first": "C", "middle": ["J"], "last": "Retterer", "suffix": ""}, {"first": "B", "middle": ["P"], "last": "Eaton", "suffix": ""}, {"first": "G", "middle": [], "last": "Pegoraro", "suffix": ""}], "year": 2014, "venue": "Nature", "volume": "508", "issn": "7496", "pages": "402--405", "other_ids": {"DOI": ["10.1038/nature13027"]}}, "BIBREF17": {"ref_id": "b17", "title": "Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease", "authors": [{"first": "M", "middle": ["L"], "last": "Agostini", "suffix": ""}, {"first": "E", "middle": ["L"], "last": "Andres", "suffix": ""}, {"first": "A", "middle": ["C"], "last": "Sims", "suffix": ""}, {"first": "R", "middle": ["L"], "last": "Graham", "suffix": ""}, {"first": "T", "middle": ["P"], "last": "Sheahan", "suffix": ""}, {"first": "X", "middle": [], "last": "Lu", "suffix": ""}, {"first": "E", "middle": ["C"], "last": "Smith", "suffix": ""}, {"first": "J", "middle": ["B"], "last": "Case", "suffix": ""}, {"first": "J", "middle": ["Y"], "last": "Feng", "suffix": ""}, {"first": "R", "middle": [], "last": "Jordan", "suffix": ""}], "year": null, "venue": "mBio", "volume": "2018", "issn": "2", "pages": "221--239", "other_ids": {"DOI": ["10.1128/mBio.00221-18"]}}, "BIBREF18": {"ref_id": "b18", "title": "Remdesivir and chloroquine effectively The Journal of Physical Chemistry Letters pubs", "authors": [{"first": "M", "middle": [], "last": "Wang", "suffix": ""}, {"first": "R", "middle": [], "last": "Cao", "suffix": ""}, {"first": "L", "middle": [], "last": "Zhang", "suffix": ""}, {"first": "X", "middle": [], "last": "Yang", "suffix": ""}, {"first": "J", "middle": [], "last": "Liu", "suffix": ""}, {"first": "M", "middle": [], "last": "Xu", "suffix": ""}, {"first": "Z", "middle": [], "last": "Shi", "suffix": ""}, {"first": "Z", "middle": [], "last": "Hu", "suffix": ""}, {"first": "W", "middle": [], "last": "Zhong", "suffix": ""}, {"first": "G", "middle": [], "last": "Xiao", "suffix": ""}], "year": 2020, "venue": "J. Phys. Chem. Lett", "volume": "11", "issn": "", "pages": "4430--4435", "other_ids": {"DOI": ["10.1021/acs.jpclett.0c00571?ref=pdf"]}}, "BIBREF19": {"ref_id": "b19", "title": "inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "authors": [], "year": null, "venue": "Cell Res", "volume": "2020", "issn": "3", "pages": "269--271", "other_ids": {"DOI": ["10.1038/s41422-020-0282-0"]}}, "BIBREF20": {"ref_id": "b20", "title": "Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides", "authors": [{"first": "S", "middle": [], "last": "Bressanelli", "suffix": ""}, {"first": "L", "middle": [], "last": "Tomei", "suffix": ""}, {"first": "F", "middle": ["A"], "last": "Rey", "suffix": ""}, {"first": "R", "middle": [], "last": "De Francesco", "suffix": ""}], "year": 2002, "venue": "J. Virol", "volume": "76", "issn": "7", "pages": "3482--3492", "other_ids": {"DOI": ["10.1128/JVI.76.7.3482-3492.2002"]}}, "BIBREF21": {"ref_id": "b21", "title": "RNA synthesis in a cage\ue0d5structural studies of reovirus polymerase \u03bb3", "authors": [{"first": "Y", "middle": [], "last": "Tao", "suffix": ""}, {"first": "D", "middle": ["L"], "last": "Farsetta", "suffix": ""}, {"first": "M", "middle": ["L"], "last": "Nibert", "suffix": ""}, {"first": "S", "middle": ["C"], "last": "Harrison", "suffix": ""}], "year": 2002, "venue": "Cell", "volume": "111", "issn": "5", "pages": "733--745", "other_ids": {"DOI": ["10.1016/S0092-8674(02)01110-8"]}}, "BIBREF22": {"ref_id": "b22", "title": "A mechanism for initiating RNA-dependent RNA polymerization", "authors": [{"first": "S", "middle": ["J"], "last": "Butcher", "suffix": ""}, {"first": "J", "middle": ["M"], "last": "Grimes", "suffix": ""}, {"first": "E", "middle": ["V"], "last": "Makeyev", "suffix": ""}, {"first": "D", "middle": ["H"], "last": "Bamford", "suffix": ""}, {"first": "D", "middle": ["I"], "last": "Stuart", "suffix": ""}], "year": 2001, "venue": "Nature", "volume": "", "issn": "6825", "pages": "235--240", "other_ids": {"DOI": ["10.1038/35065653"]}}, "BIBREF23": {"ref_id": "b23", "title": "Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance", "authors": [{"first": "H", "middle": [], "last": "Huang", "suffix": ""}, {"first": "R", "middle": [], "last": "Chopra", "suffix": ""}, {"first": "G", "middle": ["L"], "last": "Verdine", "suffix": ""}, {"first": "S", "middle": ["C"], "last": "Harrison", "suffix": ""}], "year": 1998, "venue": "Science", "volume": "282", "issn": "5394", "pages": "1669--1675", "other_ids": {"DOI": ["10.1126/science.282.5394.1669"]}}, "BIBREF24": {"ref_id": "b24", "title": "Structural basis for the 3\u2032-5\u2032 exonuclease activity of Escherichia coli DNA polymerase I: a two metal ion mechanism", "authors": [{"first": "L", "middle": ["S"], "last": "Beese", "suffix": ""}, {"first": "T", "middle": ["A"], "last": "Steitz", "suffix": ""}], "year": 1991, "venue": "EMBO J", "volume": "10", "issn": "1", "pages": "25--33", "other_ids": {"DOI": ["10.1002/j.1460-2075.1991.tb07917.x"]}}}, "ref_entries": {"FIGREF0": {"text": "Structures of SARS-CoV-2 and SARS-CoV nsp12 showing high similarity. (A) Diagram of SARSCoV-2 nsp12 with conserved motifs in each domain. (B) Modeled SARS-CoV-2 nsp12 (a.a.s 117\u2212895) and (C) SARS-CoV nsp12 (PDB: 6NUR, a.a.s 117\u2212895, 906\u2212919) structure.NiRAN is colored purple, and the interface domain is colored green. Three RdRp domains finger, palm, and thumb are colored yellow, blue, and red, respectively. Phe in motif C, one Ala 772 Ser, and one Ala 784 Ser in motif D(Figure 2A,B). The hydrogen bonds between Tyr 766 Phe and Ala 772 Ser with other a.a.s are similar, whereas Ala 784 Ser provides an additional hydrogen bond (3.2 \u00c5 to Tyr 787 ) in SARS-CoV-2 when compared with SARS CoV. The thumb domain is essential for nucleic acid binding. SARS-CoV-2 showed 100% a.a. sequence identity with SARS-CoV. However, superimposition analysis of SARS-CoV-2 and SARS-CoV RdRp suggests two structural modifications in the finger and thumb domains (", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Differences between SARS-CoV-2 and SARS-CoV RdRp. Three a.a. substitutions in motif C and motif D in the palm domain of (A) SARS-CoV-2 and (B) SARS-CoV. Hydrogen bonds connected to each atom are shown in cyan and red. (C) Superimposition of SARS-CoV-2 and SARS-CoV RdRp demonstrated two regions of dissimilarity at the start of the finger domain (a.a.s 405\u2212448, orange and cyan, respectively) and thumb domain (a.a. 835\u2212895, pink and cyan, respectively). (D) Superimposition of the nsp7 structure of SARS-CoV-2 (red) and SARS-CoV (blue). The only substitution Arg70Lys is in cyan and yellow, respectively. (E) Superimposition of the nsp8 structure of SARSCoV-2 (red) and SARS-CoV (blue).", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Docked complexes of Galidesivir (A), Favipiravir (B), and Penciclovir (C) with RdRp and their active form 2D structures. RdRp is represented as a surface, and ligands are represented as sticks. The a.a.s interacting with RdRp are colored in cyan. NiRAN is colored purple, and the interface domain is colored green. Three RdRp domains\ue0d5finger, palm, and thumb\ue0d5are colored yellow, blue, and red, respectively. The a.a.s that have a hydrogen bond or hydrophobic interaction with the drugs are shown by sticks and labeled.", "latex": null, "type": "figure"}, "TABREF0": {"text": "Percentage Identity Matrix of Different Coronavirus RdRps and Spikes A. Percentage Identity Matrix of Different Coronavirus RdRps", "latex": null, "type": "table"}, "TABREF2": {"text": "Scores Obtained for Docking of Three Clinically Used RdRp Inhibitors", "latex": null, "type": "table"}, "TABREF3": {"text": "Table 1. Percentage Identity Matrix of Di ff erent Coronavirus RdRps and Spikes", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>\u00a0</td><td>A. Percentage Identity Matrix of Different Coronavirus RdRps\n</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>HCoV-NL63 </td><td>HCoV-229E </td><td>HCoV-OC43 </td><td>MERS-CoV </td><td>SARS-CoV-2 SARS-CoV\n</td></tr><tr><td>HCoV-NL63 </td><td>\u00a0</td><td>83.74 </td><td>60.19 </td><td>63.36 </td><td>60.93 61.31\n</td></tr><tr><td>HCoV-229E </td><td>83.74 </td><td>\u00a0</td><td>60.56 </td><td>62.43 </td><td>61.31 61.68\n</td></tr><tr><td>HCoV-OC43 </td><td>60.19 </td><td>60.56 </td><td>\u00a0</td><td>73.08 </td><td>71.96 71.59\n</td></tr><tr><td>MERS-CoV </td><td>63.36 </td><td>62.43 </td><td>73.08 </td><td>\u00a0</td><td>75.51 75.89\n</td></tr><tr><td>SARS-CoV-2 </td><td>60.93 </td><td>61.31 </td><td>71.96 </td><td>75.51 </td><td>98.13\n</td></tr><tr><td>SARS-CoV </td><td>61.31 </td><td>61.68 </td><td>71.59 </td><td>75.89 </td><td>98.13\n</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>B. Percentage Identity Matrix of Different Coronavirus Spikes\n</td><td>\u00a0</td></tr><tr><td>HCoV-NL63 </td><td>HCoV-NL63 </td><td>HCoV-229E </td><td>HCoV-OC43 </td><td>MERS-CoV </td><td>SARS-CoV-2 SARS-CoV\n</td></tr><tr><td>\u00a0</td><td>63.14 </td><td>27.73 </td><td>24.44 </td><td>27.42 25.83\n</td></tr><tr><td>HCoV-229E </td><td>63.14 </td><td>\u00a0</td><td>28.43 </td><td>28.46 </td><td>28.71 28\n</td></tr><tr><td>HCoV-OC43 </td><td>27.73 </td><td>28.43 </td><td>\u00a0</td><td>33.66 </td><td>31.20 31.44\n</td></tr><tr><td>MERS-CoV </td><td>24.44 </td><td>28.46 </td><td>33.66 </td><td>\u00a0</td><td>31.93 32.27\n</td></tr><tr><td>SARS-CoV-2 </td><td>27.42 </td><td>28.71 </td><td>31.2 </td><td>31.93 </td><td>77.38\n</td></tr><tr><td>SARS-CoV </td><td>25.83 </td><td>28.00 </td><td>31.44 </td><td>32.27 </td><td>77.38\n</td></tr></table></body></html>"}}, "back_matter": [{"text": "The authors declare no competing financial interest.", "cite_spans": [], "ref_spans": [], "section": "Notes"}, {"text": "The work has been supported by the project 'Design des inhibiteurs des enzymes et prote\u00ednes pour les applications medicales et industrielles' by Fondation de CHU de Quebec (3681). We thank Dr. Muriel Kelly for her excellent language editing.", "cite_spans": [], "ref_spans": [], "section": "\u25a0 ACKNOWLEDGMENTS"}]}